Skip to main content

Table 3 Haematological Characteristics of Patients on Day 0, 7 and 28

From: Efficacy, safety and tolerability of artesunate-mefloquine in the treatment of uncomplicated Plasmodium falciparum malaria in four geographic zones of Nigeria

 

Treatment Group 1 (≥30 kg)

Treatment Group 2(15–29 kg)

 

D0

D7

D28

D0

D7

D28

Hb (mg/L)

      

   Male

11.67 ± 4.12

11.15 ± 2.37

12.19 ± 2.40

10.70 ± 2.65

9.53 ± 2.19

11.56 ± 1.34

   Female

11.47 ± 2.49

10.27 ± 1.93

11.45 ± 1.42

10.84 ± 2.99

9.07 ± 3.20

11.58 ± 1.35

ESR

23.79 ± 26.74

14.34 ± 17.23

11.82 ± 14.96

42.73 ± 29.16

18.17 ± 23.66

11.53 ± 13.52

TWBC (× 109/L)

5.27 ± 1.87

5.35 ± 1.93

5.15 ± 1.54

7.25 ± 1.11

5.91 ± 2.50

5.79 ± 4.85

Lymphocytes (× 109/L)

2.22 ± 1.05

2.59 ± 1.09

2.66 ± 1.11

2.87 ± 3.34

2.97 ± 1.69

3.14 ± 3.08

Neutrophils (× 109/L)

2.69 ± 1.28

2.55 ± 1.10

2.33 ± 0.80

4.10 ± 8.01

2.67 ± 1.21

2.47 ± 1.86

Monocytes (× 109/L)

0.24 ± 0.16

0.09 ± 0.08

0.08 ± 0.08

0.09 ± 0.11

0.08 ± 0.08

0.08 ± 0.96

Eosinophils (× 109/L)

0.12 ± 0.14

0.15 ± 0.15

0.09 ± 0.11

0.08 ± 0.11

0.15 ± 0.22

0.10 ± 0.11